Financials Qatari German Company for Medical Devices (Q.P.S.C.)

Equities

QGMD

QA0001200763

Medical Equipment, Supplies & Distribution

End-of-day quote Qatar Exchange 23:00:00 28/04/2024 BST 5-day change 1st Jan Change
1.37 QAR +1.41% Intraday chart for Qatari German Company for Medical Devices (Q.P.S.C.) -0.07% -5.58%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 65.37 67.22 258.4 367.3 145.2 167.6
Enterprise Value (EV) 1 182.6 186.3 396.9 504.2 283.8 309.8
P/E ratio -5.09 x -6.47 x 292 x 311 x 117 x 125 x
Yield - - - - - -
Capitalization / Revenue 5.73 x 8.25 x 10.5 x 9.06 x 3.4 x 6.02 x
EV / Revenue 16 x 22.9 x 16.2 x 12.4 x 6.65 x 11.1 x
EV / EBITDA -57.8 x -147 x 81.9 x 44.4 x 27 x 73.1 x
EV / FCF -209 x 80.4 x -22 x 444 x -144 x -60.5 x
FCF Yield -0.48% 1.24% -4.55% 0.23% -0.69% -1.65%
Price to Book 1.59 x 2.19 x 8.2 x 11.2 x 4.21 x 4.65 x
Nbr of stocks (in thousands) 115,500 115,500 115,500 115,500 115,500 115,500
Reference price 2 0.5660 0.5820 2.237 3.180 1.257 1.451
Announcement Date 28/03/19 30/03/20 04/03/21 16/03/22 16/03/23 08/02/24
1QAR in Million2QAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 11.4 8.144 24.57 40.55 42.66 27.85
EBITDA 1 -3.158 -1.266 4.848 11.37 10.49 4.239
EBIT 1 -8.811 -6.787 -0.6271 5.962 5.071 -1.106
Operating Margin -77.27% -83.33% -2.55% 14.7% 11.89% -3.97%
Earnings before Tax (EBT) 1 -12.83 -10.39 0.8842 1.181 1.244 1.336
Net income 1 -12.83 -10.39 0.8842 1.181 1.244 1.336
Net margin -112.55% -127.53% 3.6% 2.91% 2.92% 4.8%
EPS 2 -0.1111 -0.0899 0.007655 0.0102 0.0108 0.0116
Free Cash Flow 1 -0.8736 2.316 -18.04 1.135 -1.966 -5.121
FCF margin -7.66% 28.44% -73.45% 2.8% -4.61% -18.39%
FCF Conversion (EBITDA) - - - 9.98% - -
FCF Conversion (Net income) - - - 96.08% - -
Dividend per Share - - - - - -
Announcement Date 28/03/19 30/03/20 04/03/21 16/03/22 16/03/23 08/02/24
1QAR in Million2QAR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 117 119 139 137 139 142
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -37.11 x -94.08 x 28.57 x 12.05 x 13.21 x 33.56 x
Free Cash Flow 1 -0.87 2.32 -18 1.13 -1.97 -5.12
ROE (net income / shareholders' equity) -27% -29% 2.84% 3.68% 3.71% 3.79%
ROA (Net income/ Total Assets) -3.3% -2.68% -0.23% 2.03% 1.66% -0.35%
Assets 1 388.4 387.5 -377.5 58.31 74.91 -381.9
Book Value Per Share 2 0.3600 0.2700 0.2700 0.2800 0.3000 0.3100
Cash Flow per Share 2 0 0.0100 0.0300 0.0400 0.0500 0
Capex 1 0.25 0.09 0.66 0.56 0.25 1.05
Capex / Sales 2.18% 1.05% 2.71% 1.38% 0.59% 3.78%
Announcement Date 28/03/19 30/03/20 04/03/21 16/03/22 16/03/23 08/02/24
1QAR in Million2QAR
Estimates
  1. Stock Market
  2. Equities
  3. QGMD Stock
  4. Financials Qatari German Company for Medical Devices (Q.P.S.C.)